AKERO THERAPEUTICS, INC.

549300SI3KG74LBE2955

The entity

Status: Active
LEI status: Lapsed - not renewed
Category: Company
Legal form: Corporation (XTIQ)
Jurisdiction: US-DE
Entity created: January 24, 2017

Address

Country: United States
Legal address: c/o The Corporation Trust Company, Corporation Trust Center, 1209 Orange St19801 WilmingtonUnited States (US-DE)
Head office: 601 Gateway Boulevard, Suite 35094080 San FranciscoUnited States (US-CA)

Identifier

LEI: 549300SI3KG74LBE2955
Registered: June 3, 2019 at 02:33 PM UTC
Last updated: May 22, 2024 at 01:30 PM UTC
Next renewal: May 22, 2024 at 06:41 AM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Division of Corporations, Department of State (RA000602)
Identifier: 6294543
Verified against: Division of Corporations, Department of State (RA000602)
Verified as: 6294543
Corroboration: Confirmed against a public register
GLEIF conformity: Does not meet the standard

Corporate structure

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No parent prepares consolidated accounts including it

Machine access

REST: https://lei.online/v1/entities/549300SI3KG74LBE2955This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search